Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/8/11 申報。只含多頭部位。
- 持股檔數
- 46
- 2020 年第 4 季沒有 13F 資料
- 總值
- $3.57 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | COM | 1,175,000 | $2,627 萬 | 7.4% | – | – | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,950,000 | $2,094 萬 | 5.9% | – | – | – |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 135,000 | $1,740 萬 | 4.9% | – | – | 歷史 |
| KURAKura Oncology, Inc. | COM | 600,000 | $1,696 萬 | 4.8% | – | – | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 500,000 | $1,583 萬 | 4.4% | – | – | 歷史 |
| FATEFate Therapeutics Inc | COM | 185,000 | $1,525 萬 | 4.3% | – | – | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 850,000 | $1,522 萬 | 4.3% | – | – | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 600,000 | $1,512 萬 | 4.2% | – | – | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 325,000 | $1,442 萬 | 4.0% | – | – | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,600,000 | $1,405 萬 | 3.9% | – | – | 歷史 |
| ARVNArvinas, Inc. | COM | 205,000 | $1,355 萬 | 3.8% | – | – | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 225,000 | $965.5 萬 | 2.7% | – | – | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 200,000 | $964.0 萬 | 2.7% | – | – | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 4,143,702 | $882.6 萬 | 2.5% | – | – | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 50,000 | $856.5 萬 | 2.4% | – | – | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 939,043 | $785.0 萬 | 2.2% | – | – | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 650,000 | $772.2 萬 | 2.2% | – | – | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $728.1 萬 | 2.0% | – | – | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,125,000 | $695.3 萬 | 1.9% | – | – | 歷史 |
| iShares Russell 2000 ETF464287655 | ETF | 30,000 | $662.8 萬 | 1.9% | – | – | – |
| CNSTConstellation Pharmaceuticals Inc | COM | 275,000 | $643.2 萬 | 1.8% | – | – | 歷史 |
| BIIBBiogen Inc. | COM | 20,000 | $559.5 萬 | 1.6% | – | – | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 250,000 | $515.0 萬 | 1.4% | – | – | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $513.6 萬 | 1.4% | – | – | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $511.8 萬 | 1.4% | – | – | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 500,000 | $508.5 萬 | 1.4% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 175,000 | $508.4 萬 | 1.4% | – | – | 歷史 |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $504.0 萬 | 1.4% | – | – | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 300,000 | $501.3 萬 | 1.4% | – | – | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 500,000 | $496.4 萬 | 1.4% | – | – | 歷史 |
| CRISCuris Inc | COM NEW | 425,000 | $481.1 萬 | 1.3% | – | – | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 150,000 | $448.1 萬 | 1.3% | – | – | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 125,000 | $433.9 萬 | 1.2% | – | – | 歷史 |
| IMUXImmunic, Inc. | COM | 265,000 | $422.4 萬 | 1.2% | – | – | 歷史 |
| IMVTImmunovant, Inc. | COM | 250,000 | $401.0 萬 | 1.1% | – | – | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $344.6 萬 | 1.0% | – | – | 歷史 |
| NVAXNovavax Inc | COM NEW | 17,500 | $317.3 萬 | 0.9% | – | – | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $261.8 萬 | 0.7% | – | – | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 600,000 | $233.4 萬 | 0.7% | – | – | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 30,000 | $224.6 萬 | 0.6% | – | – | 歷史 |
| CTICCti Biopharma Corp | COM | 750,000 | $218.3 萬 | 0.6% | – | – | 歷史 |
| DTILPrecision Biosciences Inc | COM | 200,000 | $207.0 萬 | 0.6% | – | – | 歷史 |
| CMRXChimerix Inc | COM | 200,000 | $192.8 萬 | 0.5% | – | – | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $156.0 萬 | 0.4% | – | – | 歷史 |
| APVOAptevo Therapeutics Inc. | COM NEW | 50,000 | $152.6 萬 | 0.4% | – | – | 歷史 |
| OTICOtonomy, Inc. | COM | 450,000 | $114.8 萬 | 0.3% | – | – | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。